{{Rsnum
|rsid=2406342
|Chromosome=18
|position=76776324
|Orientation=plus
|GMAF=0.4339
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 42.0 | 44.6 | 13.4
| HCB | 22.1 | 48.5 | 29.4
| JPT | 28.3 | 45.1 | 26.5
| YRI | 30.6 | 51.7 | 17.7
| ASW | 31.6 | 52.6 | 15.8
| CHB | 22.1 | 48.5 | 29.4
| CHD | 21.1 | 47.7 | 31.2
| GIH | 30.3 | 54.5 | 15.2
| LWK | 22.2 | 60.2 | 17.6
| MEX | 36.2 | 53.4 | 10.3
| MKK | 28.8 | 55.1 | 16.0
| TSI | 36.3 | 51.0 | 12.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=T
  |Pval=2E-6
  |OR=1.70
  |ORtxt=[1.323-2.177]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}